Percutaneous Sclerotherapy for Giant Symptomatic Liver Hemangiomas: A Pilot Study

https://adir.tums.ac.ir/article/Percutaneous-Sclerotherapy-for-Giant-Symptomatic-Liver-Hemangiomas:-A-Pilot-Study

liver hemangiomas in 5 patients (1 man, 4 women; mean age 41.2 y) between 2016 and 2017. All patients were symptomatic (4 abdominal pain; 1 early satiety) and refused surgery. A single session of sclerotherapy with 20 cc mixture of 45 IU. Bleomycin in 10...